108 related articles for article (PubMed ID: 37821669)
1. eIF3d directs the integrated stress response.
Carim S
Nat Cell Biol; 2023 Oct; 25(10):1405. PubMed ID: 37821669
[No Abstract] [Full Text] [Related]
2. eIF3d controls the persistent integrated stress response.
Mukhopadhyay S; Amodeo ME; Lee ASY
Mol Cell; 2023 Sep; 83(18):3303-3313.e6. PubMed ID: 37683648
[TBL] [Abstract][Full Text] [Related]
3. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
4. An eIF3d-dependent switch regulates HCMV replication by remodeling the infected cell translation landscape to mimic chronic ER stress.
Thompson L; Depledge DP; Burgess HM; Mohr I
Cell Rep; 2022 May; 39(5):110767. PubMed ID: 35508137
[TBL] [Abstract][Full Text] [Related]
5. High expression of eIF3d is associated with poor prognosis in patients with gastric cancer.
He J; Wang X; Cai J; Wang W; Qin X
Cancer Manag Res; 2017; 9():539-544. PubMed ID: 29123423
[TBL] [Abstract][Full Text] [Related]
6. A phosphorylation-regulated eIF3d translation switch mediates cellular adaptation to metabolic stress.
Lamper AM; Fleming RH; Ladd KM; Lee ASY
Science; 2020 Nov; 370(6518):853-856. PubMed ID: 33184215
[TBL] [Abstract][Full Text] [Related]
7. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
[TBL] [Abstract][Full Text] [Related]
8. Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.
Maekawa M; Hiyoshi H; Nakayama J; Kido K; Sawasaki T; Semba K; Kubota E; Joh T; Higashiyama S
Biochem Biophys Res Commun; 2019 Sep; 516(4):1116-1122. PubMed ID: 31280863
[TBL] [Abstract][Full Text] [Related]
9. RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.
Ren M; Zhou C; Liang H; Wang X; Xu L
Chem Biol Drug Des; 2015 Oct; 86(4):715-22. PubMed ID: 25682860
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.
Liu GZ; Liu JZ; Li XQ; Zhang L; Li SJ; Xiao TW; Wang JX; Li GY; Liu Y
Mol Cell Biochem; 2018 Jan; 438(1-2):191-198. PubMed ID: 28801778
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.
Gao Y; Teng J; Hong Y; Qu F; Ren J; Li L; Pan X; Chen L; Yin L; Xu D; Cui X
Med Oncol; 2015 Jul; 32(7):518. PubMed ID: 26036682
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.
Yu X; Zheng B; Chai R
Biosci Rep; 2014 Dec; 34(6):e00161. PubMed ID: 25370813
[TBL] [Abstract][Full Text] [Related]
13. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
Li C; Lu K; Yang C; Du W; Liang Z
J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
[TBL] [Abstract][Full Text] [Related]
14. EIF3D promoted cervical carcinoma through Warburg effect by interacting with GRP78.
Liu Q; Liu J; Zheng D; Zhang R; Xiang Y; Xu F; Zhou X; Qin J
J Obstet Gynaecol; 2023 Dec; 43(1):2130200. PubMed ID: 36264610
[TBL] [Abstract][Full Text] [Related]
15. EIF3D promotes the progression of preeclampsia by inhibiting of MAPK/ERK1/2 pathway.
Li X; Wang Z; Liu G; Guo J
Reprod Toxicol; 2021 Oct; 105():166-174. PubMed ID: 34520790
[TBL] [Abstract][Full Text] [Related]
16. Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.
Pan Y; Zhang ZN; Yin LB; Fu YJ; Jiang YJ; Shang H
J Transl Med; 2019 May; 17(1):167. PubMed ID: 31118081
[TBL] [Abstract][Full Text] [Related]
17. hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D.
Du W; Cheng H; Peng L; Yang D; Yang C
Anticancer Drugs; 2018 Nov; 29(10):975-982. PubMed ID: 30096129
[TBL] [Abstract][Full Text] [Related]
18. EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.
Zhang F; Xiang S; Cao Y; Li M; Ma Q; Liang H; Li H; Ye Y; Zhang Y; Jiang L; Hu Y; Zhou J; Wang X; Zhang Y; Nie L; Liang X; Gong W; Liu Y
Cell Death Dis; 2017 Jun; 8(6):e2868. PubMed ID: 28594409
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.
Fan Y; Guo Y
Int J Clin Exp Pathol; 2015; 8(9):10420-7. PubMed ID: 26617750
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.
Lin Z; Xiong L; Lin Q
Med Oncol; 2015 Jul; 32(7):183. PubMed ID: 26008152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
